Foto del docente

Valentina Giunchi

Assegnista di ricerca

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Klont, Frank; Bellinga, J. Stein; Giunchi, Valentina; Balafas, Spyros; Hak, Eelko, A pharmacological view on accounting for pharmacokinetic factors in the estimation of pharmaceutical emissions based on drug usage data, «ENVIRONMENT INTERNATIONAL», 2025, 196, pp. N/A - N/A [replica/breve intervento]

Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pierantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco, Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency, «BJCP. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2025, NA, pp. N/A - N/A [articolo]

Lunghi, C.; Valetto, M. R.; Caracciolo, A. B.; Bramke, I.; Caroli, S.; Bottoni, P.; Castiglioni, S.; Crisafulli, S.; Cuzzolin, L.; Deambrosis, P.; Giunchi, V.; Grisotto, J.; Marcomini, A.; Moretti, U.; Murgia, V.; Pandit, J.; Polesello, S.; Poluzzi, E.; Romizi, R.; Scarpa, N.; Scroccaro, G.; Sorrentino, R.; Sundström, A.; Wilkinson, J.; Paolone, G., Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health, «DRUG SAFETY», 2024, 105874, pp. 1 - 6 [replica/breve intervento]

Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E., Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS, «DRUG SAFETY», 2024, 47, pp. 271 - 284 [articolo]Open Access

Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; Nekoro, M, Environmental sustainability-an essential component of rational use of medicines, «INTERNATIONAL JOURNAL OF PHARMACY PRACTICE», 2024, 33, pp. 1 - 11 [articolo]

Noseda, R.; Bedussi, F.; Giunchi, V.; Fusaroli, M.; Raschi, E.; Ceschi, A., Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2024, 12, Article number: e009902, pp. 1 - 10 [articolo]Open Access

Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E., Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System, «DRUG SAFETY», 2024, 47, pp. 1275 - 1292 [articolo]Open Access

Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors, «JTO CLINICAL AND RESEARCH REPORTS», 2023, 4, Article number: 100563, pp. 1 - 8 [articolo]Open Access

Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta, Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach, «DRUG SAFETY», 2023, 46, pp. 921 - 926 [articolo]

Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E., Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, «DRUG SAFETY», 2023, 46, pp. 283 - 295 [articolo]Open Access

Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E., Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, «PSYCHIATRY AND CLINICAL NEUROSCIENCES», 2023, 77, pp. 160 - 167 [articolo]Open Access

Valentina Giunchi, L’impatto ambientale dei farmaci sulle acque superficiali e la sua stima attraverso i dati di utilizzo, «RECENTI PROGRESSI IN MEDICINA», 2023, 114, pp. 372 - 374 [articolo]

Giunchi V.; Fusaroli M.; Linder E.; Villén J.; Wettermark B.; Nekoro M.; Raschi E.; Lunghi C.; Poluzzi E., The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 2020 - 2027 [articolo]Open Access

Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G., Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, «CANCERS», 2022, 14, Article number: 4610, pp. 1 - 13 [articolo]Open Access

Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E., Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2022, 25, pp. 727 - 736 [articolo]Open Access

Ultimi avvisi

Al momento non sono presenti avvisi.